Emyria (ASX:EMD) Share Price and News - StockTrack

Market Cap (1-Jul) $17,120,628 (923rd)	Close (30-Jun) $0.125 0 (0%)	Volume (30-Jun) 0	Shortsold (17-Apr) 8,415 (0.00%) (600th)
52w High $0.058	52w Low $0.021	P/E -	EPS 0

	Subject
	EMD EMD Ann: Notice of Annual General Meeting/Proxy Form
	1 (current) 2 3
	EMD EMD Ann: Lifesciences Webinar Presintation
	EMD EMD Ann: Novel MDMA Analogue Screening Program Advanced
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
	EMD EMD Ann: MDMA-analogues Show Promise for Parkinson's Disease
	EMD EMD Ann: Appendix 4E and Full Year Statutory Accounts
	EMD EMD Ann: Annual General Meeting
	EMD EMD Ann: Emyria Engages Calvert Labs for Preclinical CBD studies
	EMD EMD Ann: Emyria Drug Development Overview and Webinar
	EMD EMD Ann: Emyria Appoints Expert Neuropharmacologist for MDMA Program
	EMD EMD Ann: Emyria Executes Pure CBD Agreement with AltaSciences
	EMD EMD Ann: CAN: Cann and Emyria mutually end collaboration
	EMD EMD Ann: Emyria and Cann Mutually End Collaboration
	EMD EMD Ann: Emyria to Develop Novel Psychedelics Pipeline with UWA
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Principal Investigator Appointed to lead Emyria MDMA trial
	EMD EMD Ann: Results of Meeting
	EMD EMD Ann: Webinar Presentation
	EMD EMD Ann: Investor Webinar Presentation Today
	EMD EMD Ann: Emyria Advances EMD-004 Program Towards Registration
	EMD EMD Ann: Emyria Investor Webinar
	EMD EMD Ann: Emyria Data Validated, Care Model Reduces Opioids
	EMD EMD Ann: Details of Company Address
	EMD EMD Ann: Notice of General Meeting/Proxy Form
	EMD EMD Ann: Emyria Obtains TGA Approval for Medical Grade Monitoring App
	EMD EMD Ann: Trading Halt
	EMD EMD Ann: Emyria and MMA launch MDMA-assisted therapy program for PTSD
	EMD EMD Ann: Appendix 2A and Notice Under Section 708A
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Proposed issue of Securities - EMD
	EMD EMD Ann: Proposed issue of Securities - EMD
	EMD EMD Ann: $5m Placement for Drug Registration and Treatment Pipeline
	EMD EMD Ann: Trading Halt
	EMD EMD Ann: Emyria Drug Registration Model - EMD-003 snapshot
	EMD EMD Ann: CAN: Cann and Emyria investor webinar
	EMD EMD Ann: Emyria and Cann Group Investor Webinar
	EMD EMD Ann: Emyria and Cann Partner to Register CBD Product
	EMD EMD Ann: CAN: Cann and Emyria partner to register CBD product
	EMD EMD Ann: Appendix 3G
	EMD EMD Ann: Emyria CEO in multiple webinars -Wednesday 10th March
	EMD EMD Ann: Results of Meeting
	EMD EMD Ann: General Meeting Shareholder Update
	EMD EMD Ann: Emyria Adds Second Clinical Site in Perth
	EMD EMD Ann: Half Yearly Report and Accounts
	EMD EMD Ann: Global Pharmaceutical Expert joins Advisory Board
	EMD EMD Ann: Proposed issue of Securities - EMD
	EMD EMD Ann: Emyria adds second Emerald Clinic in Melbourne
	EMD EMD Ann: Emyria wins digital health monitoring grant with UWA
	EMD EMD Ann: Letter to Shareholders - General Meeting

Similar Companies

Estia Health

EHE

Japara Healthcare

JHC

Monash IVF Group

MVF

1300SMILES

ONT

Pacific Smiles Group

PSQ

Regis Healthcare

REG

Ramsay Health Care

RHC

Virtus Health

VRT

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.03	4,967,905	+0.00 (3.70%)
27-Jun	$0.03	5,758,356	+0.00 (8.00%)
26-Jun	$0.03	7,507,729	0.00 (7.41%)
24-Jun	$0.03	1,203,134	0.00 (3.57%)
23-Jun	$0.03	1,093,409	0.00 (3.45%)
20-Jun	$0.03	4,617,930	0.00 (0.00%)
19-Jun	$0.03	11,467,856	+0.00 (3.57%)
18-Jun	$0.03	14,772,303	+0.00 (12.00%)
16-Jun	$0.03	0	0.00 (0.00%)
13-Jun	$0.03	1,627,347	+0.00 (8.70%)
12-Jun	$0.02	274,691	0.00 (11.54%)
06-Jun	$0.03	237,174	+0.00 (8.33%)
05-Jun	$0.02	84,487	0.00 (0.00%)
04-Jun	$0.02	726,986	0.00 (7.69%)
03-Jun	$0.03	1,099,560	0.00 (7.14%)
6 up, 6 down, and 3 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
3 July 2025 at 5:20am

High -	Low -	Trades -	Turnover $0	Volume 0
3 July 2025 at 5:20am

Emyria Health Care

$0.125 (0%)

$0.125 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices